390 related articles for article (PubMed ID: 7543820)
1. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.
Teder P; Bergh J; Heldin P
Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
Asplund T; Heldin P
Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
[TBL] [Abstract][Full Text] [Related]
3. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
Culty M; Shizari M; Thompson EW; Underhill CB
J Cell Physiol; 1994 Aug; 160(2):275-86. PubMed ID: 7518822
[TBL] [Abstract][Full Text] [Related]
4. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
Turley EA; Austen L; Moore D; Hoare K
Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras-transformed cells.
Yang B; Hall CL; Yang BL; Savani RC; Turley EA
J Cell Biochem; 1994 Dec; 56(4):455-68. PubMed ID: 7534313
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
7. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
8. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells.
Pilarski LM; Miszta H; Turley EA
J Immunol; 1993 May; 150(10):4292-302. PubMed ID: 7683315
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition by cholera toxin of human lung carcinoma cell lines: correlation with GM1 ganglioside expression.
Kaur G; Viallet J; Laborda J; Blair O; Gazdar AF; Minna JD; Sausville EA
Cancer Res; 1992 Jun; 52(12):3340-6. PubMed ID: 1375868
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines.
Munker M; Munker R; Saxton RE; Koeffler HP
Cancer Res; 1987 Aug; 47(15):4081-5. PubMed ID: 3038306
[TBL] [Abstract][Full Text] [Related]
11. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
12. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
Uff CR; Neame SJ; Isacke CM
Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
[TBL] [Abstract][Full Text] [Related]
14. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
[TBL] [Abstract][Full Text] [Related]
19. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas.
Manda R; Kohno T; Niki T; Yamada T; Takenoshita S; Kuwano H; Yokota J
Biochem Biophys Res Commun; 2000 Aug; 275(2):440-5. PubMed ID: 10964684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]